EUVIMEDEUVIMED entdecken
Crossref

Repurposing levomilnacipran to attenuate premature ovarian insufficiency induced by cyclophosphamide in female Wistar albino rats through modulation of TLR4/p38-MAPK/NF-κB p65, caspase-3-driven apoptosis, and Klotho protein expression

Remon Roshdy Rofaeil, Ehab E Sharata, Mina Ezzat Attya, Amira M Abo-Youssef, Ramadan Am Hemeida, Marwa M Khalaf

Food and Chemical Toxicology · 2025-06 · 200 · 115406

DOI: 10.1016/j.fct.2025.115406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025-06. Verfasst von Remon Roshdy Rofaeil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt; Department of Medical Pharmacology, Faculty of …. Hauptthemen laut MEDLINE: Apoptosis, Cyclophosphamide, Caspase 3, Primary Ovarian Insufficiency. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study aims to explore the mitigative impact of levomilnacipran (LVM) against cyclophosphamide (CPA)-induced premature ovarian insufficiency by targeting TLR4/p38 MAPK/NF-κB p65, and klotho expression. METHODS: Rats were allocated into five groups as follows: control, LVM, CPA, CPA + LVM, and CPA + TRI. Serum hormones and histopathological examination were performed. To assess oxidative stress, ovarian MDA, GSH, and SOD were evaluated. The ovarian contents of caspase-3 and inflammatory markers were assessed using the ELISA method. The expression of ovarian NF-κB p65 was examined using an immunohistochemical technique. RT-qPCR was used to measure Bax and Bcl-2 mRNA expression. Utilizing a Western blot, the TLR4, p38 MAPK, α-Klotho, and cleaved caspase-3 levels were estimated. The estrous cycle was also monitored. FINDINGS: LVM attenuated CPA-induced ovarian toxicity by regulating hormones and alleviating histopathological aberrations. It also raised SOD and GSH levels and lowered MDA's ovarian content. Moreover, Bcl-2 levels were raised, Bax and caspase-3 expression levels were reduced, and IL-18, IL-1β, and TNF-α levels were all reduced. LVM-induced ovarian protection by diminishing TLR4/p38 MAPK/NF-κB p65 expression and boosting the protein levels of α-Klotho. SIGNIFICANCE: LVM mitigated POI caused by CPA by downregulating TLR4/p38 MAPK/NF-κB p65, enhancing the α-Klotho level and attenuating caspase-3 derived apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCyclophosphamideCaspase 3Primary Ovarian InsufficiencyGlucuronidaseAnimalsFemaleToll-Like Receptor 4Klotho ProteinsRats, WistarRatsp38 Mitogen-Activated Protein KinasesTranscription Factor RelAOxidative StressOvary

Stichwörter der Autor:innen

Caspase-3CyclophosphamideLevomilnacipranPremature ovarian insufficiencyTLR4α-Klotho

Substanzen

Toll-Like Receptor 4CyclophosphamideKlotho ProteinsCaspase 3p38 Mitogen-Activated Protein KinasesTlr4 protein, ratTranscription Factor RelAGlucuronidaseCasp3 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt; Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia, 61519, Egypt. Electronic address: r…
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt. Electronic address: ehab.essam@deraya.edu.eg.
  • Department of Pathology, Faculty of Medicine, Minia University, Minia, 61519, Egypt. Electronic address: mena.ezzat@mu.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: amira.abouyousif@pharm.bsu.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt. Electronic address: ramadan.hemeida@deraya.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: marwa.khalaf@pharm.bsu.edu.eg.

Zitieren

APA

Rofaeil, R. R., Sharata, E. E., Attya, M. E., Abo-Youssef, A. M., Hemeida, R. A., & Khalaf, M. M. (2025). Repurposing levomilnacipran to attenuate premature ovarian insufficiency induced by cyclophosphamide in female Wistar albino rats through modulation of TLR4/p38-MAPK/NF-κB p65, caspase-3-driven apoptosis, and Klotho protein expression. Food and Chemical Toxicology, 200, 115406. https://doi.org/10.1016/j.fct.2025.115406

Vancouver

Rofaeil RR, Sharata EE, Attya ME, Abo-Youssef AM, Hemeida RA, Khalaf MM. Repurposing levomilnacipran to attenuate premature ovarian insufficiency induced by cyclophosphamide in female Wistar albino rats through modulation of TLR4/p38-MAPK/NF-κB p65, caspase-3-driven apoptosis, and Klotho protein expression. Food and Chemical Toxicology. 2025;200:115406. doi:10.1016/j.fct.2025.115406

BibTeX
@article{Rofaeil2025,
  author = {Rofaeil, Remon Roshdy and Sharata, Ehab E and Attya, Mina Ezzat and Abo-Youssef, Amira M and Hemeida, Ramadan Am and Khalaf, Marwa M},
  title = {Repurposing levomilnacipran to attenuate premature ovarian insufficiency induced by cyclophosphamide in female Wistar albino rats through modulation of TLR4/p38-MAPK/NF-κB p65, caspase-3-driven apoptosis, and Klotho protein expression},
  journal = {Food and Chemical Toxicology},
  year = {2025},
  volume = {200},
  pages = {115406},
  doi = {10.1016/j.fct.2025.115406}
}
Kostenlos starten →